Skip to main content
SpringerLink
Log in

Cardiovascular evaluation in advanced chronic kidney disease

Kardiovaskuläre Abklärung bei fortgeschrittener Niereninsuffizienz

  • Main topic
  • Published:
Herz Aims and scope Submit manuscript

Abstract

Patients with chronic kidney disease (CKD) display an increased cardiovascular comorbidity, which is often underdiagnosed. Thus, effective cardiovascular diagnostic testing is of particular importance for this group of patients. Data from prospective randomized trials with cardiovascular diagnostic testing in CKD patients and improved outcome are limited. Diagnostic stress testing for CKD patients requires special consideration. Guidelines recommend cardiovascular diagnostic testing for patients undergoing an evaluation before transplantation.

Zusammenfassung

Patienten mit chronischer Niereninsuffizienz weisen eine erhöhte kardiovaskuläre Mortalität auf, welche jedoch häufig unterdiagnostiziert ist. Daher erscheint eine effektive kardiovaskuläre Diagnostik für diese Patienten essenziell. Prospektive randomisierte Studien zu kardiovaskulärer Diagnostik bei Patienten mit chronischer Niereninsuffizienz und einer Prognoseverbesserung sind nur begrenzt verfügbar. Vor allem die Ischämiediagnostik stellt eine besondere Herausforderung bei Patienten mit chronischer Niereninsuffizienz dar. Leitlinien empfehlen kardiovaskuläre Diagnostik bei Patienten, bei denen eine Abklärung vor Nierentransplantation durchgeführt wird.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ravani P, Fiocco M, Liu P et al (2019) Influence of mortality on estimating the risk of kidney failure in people with stage 4 CKD. J Am Soc Nephrol 30(11):2219–2227

    Article  Google Scholar 

  2. Go AS, Bansal N, Chandra M et al (2011) Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J Am Coll Cardiol 58(15):1600–1607

    Article  Google Scholar 

  3. Herzog CA, Littrell K, Arko C et al (2007) Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 116(13):1465–1472

    Article  Google Scholar 

  4. Gunsolus I, Sandoval Y, Smith SW et al (2018) Renal dysfunction influences the diagnostic and prognostic performance of high-sensitivity cardiac troponin I. J Am Soc Nephrol 29(2):636–643

    Article  CAS  Google Scholar 

  5. Sarnak MJ, Amann K, Bangalore S et al (2019) Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 74(14):1823–1838

    Article  CAS  Google Scholar 

  6. Colbert G, Jain N, de Lemos JA, Hedayati SS (2015) Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD. Clin J Am Soc Nephrol 10(3):515–529

    Article  CAS  Google Scholar 

  7. Mach F, Baigent C, Catapano AL et al (2020) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111–188

    Article  Google Scholar 

  8. Bhatti NK, Karimi Galougahi K, Paz Y et al (2016) Diagnosis and management of cardiovascular disease in advanced and end-stage renal disease. J Am Heart Assoc 5(8):e3648

    Article  Google Scholar 

  9. Rajagopalan N, Miller TD, Hodge DO et al (2005) Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 45(1):43–49

    Article  Google Scholar 

  10. Buerschaper L, Floege J, Muhlfeld A, Schlieper G (2019) Evaluation of electrocardiographic parameters predicting cardiovascular events in patients with end-stage renal disease before and after transplantation. Kidney Blood Press Res 44(4):615–627

    Article  Google Scholar 

  11. Wang LW, Fahim MA, Hayen A et al (2011) Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008691.pub2

    Article  PubMed  PubMed Central  Google Scholar 

  12. Wang LW, Masson P, Turner RM et al (2015) Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review. Transplantation 99(4):731–745

    Article  Google Scholar 

  13. Weir MR (2015) Is there an optimal strategy for pretransplant cardiovascular screening? Transplantation 99(4):656–657

    Article  Google Scholar 

  14. Almendarez M, Gurm HS, Mariani J Jr. et al (2019) Procedural strategies to reduce the incidence of contrast-induced acute kidney injury during percutaneous coronary intervention. JACC Cardiovasc Interv 12(19):1877–1888

    Article  Google Scholar 

  15. Weisbord SD, Gallagher M, Jneid H et al (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 378(7):603–614

    Article  CAS  Google Scholar 

  16. Poldermans D, Bax JJ, Schouten O et al (2006) Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 48(5):964–969

    Article  CAS  Google Scholar 

  17. Young LH, Wackers FJ, Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 301(15):1547–1555

    Article  CAS  Google Scholar 

  18. Maron DJ, Hochman JS, Reynolds HR et al (2020) Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382(15):1395–1407

    Article  Google Scholar 

  19. Bangalore S, Maron DJ, O’Brien SM et al (2020) Management of coronary disease in patients with advanced kidney disease. N Engl J Med 382(17):1608–1618

    Article  CAS  Google Scholar 

  20. Lentine KL, Brennan DC, Schnitzler MA (2005) Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 16(2):496–506

    Article  Google Scholar 

  21. Friedman SE, Palac RT, Zlotnick DM et al (2011) A call to action: variability in guidelines for cardiac evaluation before renal transplantation. Clin J Am Soc Nephrol 6(5):1185–1191

    Article  Google Scholar 

  22. Erarbeitet durch die Arbeitsgemeinschaft der Nierentransplantationszentren Nordrhein-Westfalens, vertreten durch die Mitglieder. MANUAL zur Vereinheitlichung der Evaluation vor Nierentransplantation und Nierenlebendspende, der Wartelistenführung vor Nierentransplantation und zur Nachsorge nach Nierentransplantation und Nierenlebendspende. 2018; https://www.d-t-g-online.de/images/Downloads/Manual_Nierentransplantation_10-2018.pdf. Accessed 17.02.21

  23. Ying T, Gill J, Webster A et al (2019) Canadian-Australasian Randomised trial of screening kidney transplant candidates for coronary artery disease—a trial protocol for the CARSK study. Am Heart J 214:175–183

    Article  Google Scholar 

  24. Marwick TH, Lauer MS, Lobo A et al (1998) Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. J Intern Med 244(2):155–161

    Article  CAS  Google Scholar 

  25. Bergeron S, Hillis GS, Haugen EN et al (2007) Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J 153(3):385–391

    Article  Google Scholar 

  26. De Vriese AS, Vandecasteele SJ, Van den Bergh B, De Geeter FW (2012) Should we screen for coronary artery disease in asymptomatic chronic dialysis patients? Kidney Int 81(2):143–151

    Article  Google Scholar 

  27. Dilsizian V, Gewirtz H, Marwick TH et al (2020) JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2020.05.035

    Article  PubMed  PubMed Central  Google Scholar 

  28. Bajaj NS, Singh A, Zhou W et al (2020) Coronary microvascular dysfunction, left ventricular remodeling and clinical outcomes in patients with chronic kidney impairment. Circulation 141(1):21–33

    Article  Google Scholar 

  29. Mangion K, McDowell K, Mark PB, Rutherford E (2018) Characterizing cardiac involvement in chronic kidney disease using CMR‑a systematic review. Curr Cardiovasc Imaging Rep 11(1):2

    Article  Google Scholar 

  30. Kramann R, Erpenbeck J, Schneider RK et al (2014) Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD. J Am Soc Nephrol 25(10):2351–2365

    Article  CAS  Google Scholar 

  31. Wizemann V, Tong L, Satayathum S et al (2010) Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 77(12):1098–1106

    Article  CAS  Google Scholar 

  32. Wong MCG, Kalman JM, Pedagogos E et al (2015) Bradycardia and asystole is the predominant mechanism of sudden cardiac death in patients with chronic kidney disease. J Am Coll Cardiol 65(12):1263–1265

    Article  Google Scholar 

  33. Roy-Chaudhury P, Tumlin JA, Koplan BA et al (2018) Primary outcomes of the monitoring in dialysis study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle. Kidney Int 93(4):941–951

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Nephrology, Hypertension, and Metabolic Diseases, Heidering 31, 30625, Hannover, Germany

    Georg Schlieper

Authors
  1. Georg Schlieper
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georg Schlieper.

Ethics declarations

Conflict of interest

G. Schlieper declares that he has no competing interests.

For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schlieper, G. Cardiovascular evaluation in advanced chronic kidney disease. Herz 46, 212–216 (2021). https://doi.org/10.1007/s00059-021-05028-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-021-05028-z

Keywords

Schlüsselwörter

Search

Navigation